Feb 20, 2020 04:01PM
Feb 20, 2020 04:01PM
Feb 3, 2020 07:10AM
Nov 15, 2019 09:23AM
Nov 14, 2019 04:35PM
Nov 14, 2019 04:30PM
Nov 14, 2019 04:30PM Agile Therapeutics Announces FDA Extension of Twirla® NDA Review Period
Oct 31, 2019 09:06AM
Oct 31, 2019 07:48AM
Oct 31, 2019 06:28AM
Oct 31, 2019 06:26AM
Oct 30, 2019 06:33PM
Oct 30, 2019 06:33PM
Oct 28, 2019 08:18AM Agile Therapeutics (AGRX) Provides Twirla Update, Other Recent Corporate Developments
Oct 28, 2019 08:00AM
Oct 28, 2019 08:00AM
Aug 1, 2019 08:00AM
Aug 1, 2019 08:00AM
Jul 18, 2019 07:36AM
Jul 18, 2019 07:30AM
Jul 18, 2019 07:30AM Agile Therapeutics Appoints Chief Financial Officer
Jun 24, 2019 04:17PM
Jun 24, 2019 04:15PM
Jun 24, 2019 04:15PM
May 22, 2019 07:01AM
May 22, 2019 07:00AM
May 22, 2019 07:00AM
May 17, 2019 07:31AM Agile Therapeutics (AGRX) Announces NDA Resubmission to FDA for Transdermal Low-Dose Contraceptive Patch, Twirla
May 17, 2019 07:30AM
May 17, 2019 07:30AM
May 2, 2019 04:15PM
May 2, 2019 04:15PM
Apr 12, 2019 06:28AM
Mar 12, 2019 04:15PM
Mar 12, 2019 04:15PM Agile Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 4, 2019 07:32AM
Mar 4, 2019 07:30AM
Mar 4, 2019 07:30AM
Feb 11, 2019 07:37AM
Feb 11, 2019 07:30AM
Feb 11, 2019 07:30AM
Jan 10, 2019 04:27PM Agile Therapeutics (AGRX) Provides Regulatory Update and Reiterates Cash Guidance
Jan 10, 2019 04:15PM
Jan 10, 2019 04:15PM
Dec 13, 2018 04:20PM
Dec 13, 2018 04:15PM
Dec 13, 2018 04:15PM
Nov 1, 2018 04:15PM
Nov 1, 2018 04:15PM Agile Therapeutics Reports Third Quarter 2018 Financial Results
Oct 24, 2018 08:09AM

15,404 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All